文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

帕金森病中黑质的回声性及其与临床发现的关系。

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.

作者信息

Berg D, Siefker C, Becker G

机构信息

Department of Neurology, University of Würzburg.

出版信息

J Neurol. 2001 Aug;248(8):684-9. doi: 10.1007/s004150170114.


DOI:10.1007/s004150170114
PMID:11569897
Abstract

Recently an increased echogenicity of the substantia nigra (SN) in patients with Parkinson's disease (PD) was demonstrated by transcranial ultrasound (TCS). In this study we set out to compare SN echogenicitiy with disease characteristics (time of onset, duration, toxin exposure) in a large patients sample. Patients' history and exposure to toxins were recorded from 112 PD patients who underwent a thorough neurological examination including assessment of disease stage according to Hoehn and Yahr and CURS (Columbia University Rating Scale). Personality was assessed according to the Freiburg Personality Inventory. In all patients the area of SN echogenicity was encircled and measured by TCS. All except 9 patients had hyperechogenic SN areas exceeding the mean plus standard deviation values of an age matched control group (0.19 cm2). The age of disease onset was lower in patients who displayed an area of SN echogenicity above this value. The area of SN echogenicity was larger contralateral to the side with more severe symptoms. None of the other characteristics correlated with ultrasound findings. We conclude that SN hyperechogenicity is a typical finding in PD. The cause of hyperechogenicity is so far unknown. Investigation of the underlying reason might disclose a pathogenic factor in PD.

摘要

最近,经颅超声检查(TCS)显示帕金森病(PD)患者黑质(SN)的回声增强。在本研究中,我们着手在大量患者样本中比较黑质回声与疾病特征(发病时间、病程、毒素暴露情况)。记录了112例接受全面神经系统检查的帕金森病患者的病史和毒素暴露情况,检查包括根据Hoehn和Yahr以及CURS(哥伦比亚大学评定量表)评估疾病阶段。根据弗莱堡人格问卷评估人格。对所有患者均采用经颅超声检查环绕并测量黑质回声区域。除9例患者外,所有患者的黑质高回声区域均超过年龄匹配对照组的平均值加标准差(0.19平方厘米)。黑质回声区域超过该值的患者发病年龄较低。症状较重一侧对侧的黑质回声区域更大。其他特征均与超声检查结果无相关性。我们得出结论,黑质高回声是帕金森病的典型表现。目前尚不清楚高回声的原因。对其潜在原因的研究可能会揭示帕金森病的致病因素。

相似文献

[1]
Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.

J Neurol. 2001-8

[2]
Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.

Ultrasound Med Biol. 2019-1

[3]
Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

Brain. 2007-7

[4]
Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.

J Parkinsons Dis. 2018

[5]
Hyperechogenicity of the substantia nigra in Parkinson's disease.

J Neuroimaging. 2007-4

[6]
Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.

Neurology. 1995-1

[7]
Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.

Parkinsonism Relat Disord. 2016-3

[8]
Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.

Neurol Sci. 2019-11-22

[9]
Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.

Chin Med J (Engl). 2017-10-5

[10]
Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.

Mov Disord. 2007-3-15

引用本文的文献

[1]
Clinical and Genetic Characteristics of Parkinson's Disease Patients with Substantia Nigra Hyperechogenicity.

Int J Mol Sci. 2025-6-8

[2]
High correlation of quantitative susceptibility mapping and echo intensity measurements of nigral iron overload in Parkinson's disease.

J Neural Transm (Vienna). 2025-3

[3]
Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodies.

Alzheimers Res Ther. 2024-10-15

[4]
Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directions.

Front Neurol. 2024-9-19

[5]
Systematic review-based guideline "Parkinson's disease" of the German Society of Neurology: diagnostic use of transcranial sonography.

J Neurol. 2024-12

[6]
Transcranial Sonography Characteristics of Cerebellar Neurodegenerative Ataxias.

Brain Sci. 2024-3-30

[7]
Segmentation of Substantia Nigra in Brain Parenchyma Sonographic Images Using Deep Learning.

J Imaging. 2023-12-19

[8]
How should we be using biomarkers in trials of disease modification in Parkinson's disease?

Brain. 2023-12-1

[9]
Prevention of Parkinson's Disease: From Risk Factors to Early Interventions.

CNS Neurol Disord Drug Targets. 2024

[10]
Assessment of different regions of interest-based methods for [99mTc]Tc DAT-SPECT quantification using an anthropomorphic striatal phantom.

EJNMMI Phys. 2022-12-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索